These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15930411)

  • 21. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of B-type natriuretic peptide outside of the emergency department.
    Maeder MT; Mueller C; Pfisterer ME; Buser PT; Brunner-La Rocca HP
    Int J Cardiol; 2008 Jun; 127(1):5-16. PubMed ID: 18191484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of B-type natriuretic peptide in patients with left bundle-branch block admitted for acute heart failure.
    Aspromonte N; Valle R; Di Fusco SA; Santini M; Feola M
    Eur J Intern Med; 2011 Dec; 22(6):e152-4. PubMed ID: 22075309
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure and B-type natriuretic protein.
    Hoyne J
    Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide - a biomarker for all seasons?
    Mark DB; Felker GM
    N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Souverijn JH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):231; author reply 231. PubMed ID: 18320951
    [No Abstract]   [Full Text] [Related]  

  • 31. Analytical performance vs clinical use of natriuretic peptide measurements.
    Andrade DM; Vidigal PG; Eloi-Santos SM
    Arch Intern Med; 2010 Jul; 170(14):1274; author reply 1275. PubMed ID: 20660853
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations.
    van Kimmenade RR; Pinto YM; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):39-42. PubMed ID: 18243857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide and the stressed heart.
    Nohria A; Givertz MM
    J Am Coll Cardiol; 2006 Feb; 47(4):749-51. PubMed ID: 16487839
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
    Katz JN; Drazner MH
    Am Heart J; 2005 Jul; 150(1):1-3. PubMed ID: 16084142
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
    Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
    Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.